Picture of Intra-Cellular Therapies logo

ITCI — Intra-Cellular Therapies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Intra-Cellular Therapies Says Entered Into New Supply Agreement With Siegfried AG

Jan 9 (Reuters) - Intra-Cellular Therapies Inc  ITCI.O :
    * INTRA-CELLULAR THERAPIES INC -  ON JANUARY 5, ENTERED INTO
A NEW
SUPPLY AGREEMENT WITH SIEGFRIED AG
    * INTRA-CELLULAR THERAPIES INC - INITIAL TERM OF THE
SIEGFRIED
AGREEMENT EXTENDS FOR THREE YEARS UNTIL JANUARY 5, 2026
    * INTRA-CELLULAR THERAPIES- UNDER AGREEMENT, SIEGFRIED TO
MANUFACTURE, SUPPLY ACTIVE PHARMACEUTICAL INGREDIENT USED IN
CAPLYTA IN COMMERCIAL QUANTITIES
    * INTRA-CELLULAR THERAPIES - UNDER AGREEMENT, PURCHASE
PRICES FOR
SUPPLY OF PRODUCT FROM SIEGFRIED SPECIFIED PRICES BASED ON
VOLUME OF PRODUCT PRODUCED

Further company coverage:  ITCI.O 
 ((reuters.briefs@thomsonreuters.com;))

Recent news on Intra-Cellular Therapies

See all news